Abilify MyCite

Indicated For

schizophrenia, bipolar I disorder, major depressive disorder

About This Medication

# Otsuka Patient Assistance Foundation Patient Guide: How to Get Abilify MyCite at Low or No Cost Abilify MyCite (aripiprazole tablets with sensor) is a unique digital medicine for adults with schizophrenia, bipolar I disorder, or major depressive disorder (MDD) as an add-on treatment. The **Otsuka Patient Assistance Foundation (OPAF)** provides this medication at no cost to eligible uninsured or underinsured patients who meet income guidelines, helping ensure access to this innovative treatment that tracks medication ingestion via a sensor, patch, app, and dashboard.[1][3][6] ## About Abilify MyCite Abilify MyCite combines **aripiprazole**, an antipsychotic medication, with an ingestible sensor embedded in the tablet. When swallowed, the sensor activates in your stomach and sends a signal to a wearable **MYCITE Patch** on your body. This data syncs to a free smartphone **MYCITE app** and a web-based dashboard for you, your doctor, and caregivers to review. It's designed to help confirm if you've taken your dose, though it doesn't guarantee better adherence or dose changes—always follow your doctor's guidance.[3][2][4] **FDA-approved uses** include: - Treatment of schizophrenia in adults. - Acute and maintenance treatment of bipolar I disorder (manic or mixed episodes), alone or with lithium/valproate. - Add-on treatment for major depressive disorder (MDD) in adults.[3][6] **Important safety note**: Like other aripiprazole products, it carries risks like increased suicidal thoughts (especially in younger adults), unusual movements, and metabolic changes. Read the full Medication Guide, keep doctor visits, and report side effects to FDA at 1-800-FDA-1088.[3] The system launched in 2017 with a limited rollout to select health plans and providers to refine the technology based on real-world use.[2][4] ## Who Qualifies for OPAF? OPAF helps U.S. patients who lack insurance coverage or face high costs for Otsuka medications. While exact income thresholds aren't publicly detailed here, programs like OPAF typically base eligibility on **federal poverty level (FPL)**, often up to 400% FPL or similar for individuals/families. You generally qualify if: - You're a U.S. resident. - Uninsured or insurance doesn't cover Abilify MyCite. - Have a valid prescription for an OPAF-supported medication (note: Abilify MyCite coverage may align with similar products like ABILIFY MAINTENA).[1][10] - Meet income limits (proof required). Contact OPAF or Otsuka support for your specific situation, as Abilify MyCite's digital features may involve select provider networks.[1][7] ## Income Eligibility Breakdown | Household Size | Max Annual Income (est. 400% FPL, 2026) | Notes | |---------------|-----------------------------------------|-------| | 1 (Individual) | ~$60,000 | Approximate; verify with OPAF[1] | | 2 (Couple) | ~$81,000 | Based on typical PAP guidelines | | 3 | ~$102,000 | Income proof like tax returns needed | | 4 | ~$122,000 | Add ~$20,000 per additional member | *These are estimates from standard patient assistance programs (PAPs). OPAF may use a different FPL percentage (e.g., 300-500%). Always confirm via application.[1][10]* ## Insurance Requirements OPAF is primarily for **uninsured patients** or those whose insurance denies coverage for Abilify MyCite. Medicare, Medicaid, or commercial plans may cover standard Abilify but not always the MyCite sensor version due to its novelty. If insured: - Exhaust insurance options first (e.g., prior authorization). - OPAF won't cover if insurance pays. - Medicare Part D patients: Check copay assistance via Otsuka savings card (as low as $5/month for standard Abilify, may apply).[5][7] For **Medicare**: PAPs like OPAF often exclude those with creditable coverage, but co-pay help may be available through other Otsuka programs or Patient Advocate Foundation.[8] ## Step-by-Step Application Process 1. **Get a prescription**: Ask your doctor for Abilify MyCite. They may need to enroll in the MyCite provider portal.[9] 2. **Visit OPAF website**: Go to otsukapatientassistance.com. Download the patient enrollment form.[1][10] 3. **Complete the form**: Include doctor signature, your info, income details, and proof (e.g., pay stubs, tax return). 4. **Gather documents**: Typically tax returns, proof of income/residency, prescription, insurance denial (if applicable).[10] 5. **Submit**: Mail or fax the form. Call Otsuka Patient Support at **1-833-468-7852** (M-F, 8AM-8PM ET) for help or MyCite-specific support at **844-MYCITE-D (844-692-4833)**.[7][9] 6. **Wait for approval**: Processing varies (see FAQ). ## Timeline and Delivery Approval can take 2-4 weeks, though urgent cases may be faster. Once approved, medication ships directly to your home or doctor's office at **no cost** for up to 12 months (renewal needed). Refills follow the same process or auto-ship if set up.[1][10] ## Alternatives if Denied or Ineligible - **Otsuka Savings Card**: Pay as low as $5 for 30-day supply of Abilify (check MyCite applicability).[5] - **State Medicaid**: Apply via benefits.gov; may cover fully.[8] - **Patient Advocate Foundation Co-Pay Relief**: For copays/coinsurance if insured.[8] - **NowPatient or similar**: Coupons/discounts up to 90% off.[8] - **Standard Abilify**: Non-sensor version often cheaper/covered; discuss with doctor.[5] - **Biosimilars**: None listed for MyCite; generic aripiprazole available for other forms. If denied, reapply with updated info or appeal.[1] ## Disclaimer This guide is for informational purposes only and not medical/financial advice. Eligibility, terms, and availability can change—contact OPAF directly for latest details. Always consult your healthcare provider before starting/stopping Abilify MyCite. Otsuka disclaims liability for use of this info. Data current as of available sources; visit otsukapatientassistance.com.[1][3]

Program information last verified: March 30, 2026